Anti-Cancer Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in medicinal chemistry and rational drug design for the discovery of anti-cancer agents.
Each issue contains a series of timely in-depth reviews and guest edited issues written by leaders in the field covering a range of current topics in cancer medicinal chemistry. The journal only considers high quality research papers for publication.
Anti-Cancer Agents in Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments in cancer drug discovery.
Articles from the journal Anti-Cancer Agents in Medicinal Chemistry 16, Issue 12:
- Statins and Alkylphospholipids as New Anticancer Agents Targeting Lipid Metabolism
- Brain-metastatic Breast Cancer: Clinical Considerations and Pharmacological Approaches
- Circulating Tumor Cells: A New Window for Diagnosis and Evaluation of Cancer
- Peroxisome Proliferator-Activated Receptors and their Ligands in Cancer Drug- Resistance: Opportunity or Challenge
- Novel Therapeutic Strategies Against Cancer: Marine-derived Drugs May Be the Answer?
- Mutant B-Raf Kinase Inhibitors as Anticancer Agents
- Selective Toxicity of Apigenin on Cancerous Hepatocytes by Directly Targeting their Mitochondria
- Synthesis and in vitro Evaluation of the Anticancer Potential of New Aminoalkanol Derivatives of Xanthone
- In Vivo Inhibition of Proteasome Activity and Tumour Growth by Murraya koenigii Leaf Extract in Breast Cancer Xenografts and by Its Active Flavonoids in Breast Cancer Cells
- Aryl Maleimides as Apoptosis Inducers on L5178-Y Murine Leukemia Cells (in silico, in vitro and ex vivo Study)
- A Novel Method to Synthesize 4-Aryl-1H-1,2,3-Triazoles and its Antihepatoma Activity
- Trans-platinum(II)/(IV) Complexes with Acetylpyridine Ligands as Antivascular Agents in vitro: Cytotoxic and Antiangiogenic Potential
- The cytotoxic effect of GW843682X on nasopharyngeal carcinoma
- In Vitro Anticancer Effects of Two New Potent Hydrazide Compounds on Leukemic Cells
- 4-Anilinoquinazoline Derivatives with Epidermal Growth Factor Receptor Inhibitor Activity
- Pyrrolidino Analogues of Gefitinib with Improved EGFR Inhibition, Cancer Cell Cytotoxicity, and Pharmacokinetic Properties